| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |